Close X
Thursday, November 21, 2024
ADVT 
Health

Coffee may cut severity of fatty liver disease in diabetics

Darpan News Desk IANS, 12 Jan, 2023 01:44 PM
  • Coffee may cut severity of fatty liver disease in diabetics

Photo courtesy of IStock. 

Caffeine, polyphenols, and other natural products found in coffee may help reduce the severity of non-alcoholic fatty liver disease (NAFLD) among overweight people with type 2 diabetes (T2D), a new study has shown.

NAFLD is a collective term for liver disorders caused by a build-up of fat in the liver. These can lead to liver fibrosis, which can progress to cirrhosis (scarring of the liver) and liver cancer, according to a study by the Portugal-based University of Coimbra.

The main cause of NAFLD is not excessive alcohol consumption, but rather an unhealthy lifestyle with little physical activity and a high-calorie diet.

"Due to changes in modern diet and lifestyle, there is an increase in obesity rates and incidence of both T2D and NAFLD, which can ultimately develop into more severe and irreversible conditions, burdening healthcare systems," said the corresponding author of the study, John Griffith Jones, PhD, Senior Researcher at the University of Coimbra, Portugal.

"Our research is the first to observe that higher cumulative amounts of both caffeine and non-caffeine metabolites in urine are associated with a reduced severity of NAFLD in overweight people with T2D," he added.

In the study, participants who consumed more coffee had healthier livers, but subjects who consumed more caffeine were less likely to develop liver fibrosis, whereas patients who consumed more non-caffeine coffee components had a lower fatty liver index score.

The study suggests that for overweight type 2 diabetes patients, a higher intake of coffee is associated with less severe NAFLD.

Additionally, the study cited that other coffee components, including polyphenols, reduce oxidative stress in the liver, in turn reducing the risk of fibrosis as well as improving glucose homeostasis in both healthy and overweight subjects.

All these factors may also alleviate the severity of T2D, the study mentioned.

MORE Health ARTICLES

UN cautions that virus plasma treatment still experimental

UN cautions that virus plasma treatment still experimental
The World Health Organization on Monday cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy, voicing the concern as a U.S. boost for the treatment has many scientists afraid formal studies will be derailed.

UN cautions that virus plasma treatment still experimental

Pandemic pushes expansion of 'hospital-at-home' treatment

Pandemic pushes expansion of 'hospital-at-home' treatment
As hospitals care for people with COVID-19 and try to keep others from catching the virus, more patients are opting to be treated where they feel safest: at home.

Pandemic pushes expansion of 'hospital-at-home' treatment

Pharmacists can give childhood shots, U.S. officials say

Pharmacists can give childhood shots, U.S. officials say
Pharmacists in all 50 states are now allowed to give childhood vaccinations under a new directive aimed at preventing future outbreaks of measles and other preventable diseases.

Pharmacists can give childhood shots, U.S. officials say

Trail of bubbles leads scientists to new coronavirus clue

Trail of bubbles leads scientists to new coronavirus clue
A doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot.

Trail of bubbles leads scientists to new coronavirus clue

FDA blocks much-anticipated BioMarin hemophilia gene therapy

FDA blocks much-anticipated BioMarin hemophilia gene therapy
Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime treatment.

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Many steps needed for accurate COVID-19 test results

Many steps needed for accurate COVID-19 test results
A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don't follow the the latest updates from the manufacturer.

Many steps needed for accurate COVID-19 test results